Australia, July 29 -- Edgewise Therapeutics Inc., owns the trademark (2546053) for 'WAYBRI' till April 2, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases; anti-inflammatories.]
Type of Mark: Word
Date of Acceptance: May 20
Registration Advertised: July 28
For further details contact Aaron D. Hendelman WILSON SONSINI ...